Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters








Language
Year range
1.
China Medical Equipment ; (12): 96-98,99, 2014.
Article in Chinese | WPRIM | ID: wpr-570643

ABSTRACT

Objective:To study the correlation between time window and effects of urokinase thrombolytic therapy in treating STEMI. Methods: STEMI patients in our hospital were enrolled and randomly divided observation group received thrombolytic therapy within 3 h after infarction and control group received thrombolytic therapy 3-6 h after infarction. Then myocardial cells necrosis index and ventricular diastolic function indexes were detected. Results: (1)cTnT, LDH,CK-MB levels of observation group were lower than those of control group and positively correlated with thrombolysis time; (2)E peak, E/A value, LVEF, LVEDD of observation group were higher than those of control group and negatively correlated with of thrombolysis time. Conclusion:short thrombolysis time has positive clinical value in treating STEMI for the myocardial necrosis is less and ventricular function recovery is better.

2.
Clinical Medicine of China ; (12): 133-135, 2009.
Article in Chinese | WPRIM | ID: wpr-396384

ABSTRACT

Objective To investigate the therapeutic value of Shuxuetong injection in patients with acute coronary syndrome(ACS).Methods 89 ACS patients were divided randomly into two groups: control group(n =44) and experimental group(n=45).The conventional therapy was used in the control group while Shuxuetong was added in the experimental group.The course of treatment was two weeks.Thromboxane B2(TXB2) and 6-keto-prosta-glandin F1a (6-K-PGF1a) were detected by radio-immunity before and after therapy.Homocysteine were tested by corpuscle enzyme linked immunosorbent assay.Results TXB2 was obviously lower in the experimental group [(554.2±303.2) ng/L] and the control group [(737.2±299.3 ) ng/L ] after treatment than that before treatment (P<0.05).Homocysteine was obviously lower in the experimental group [(10.42±2.99 )μmol/L ] and the control group [(16.39±2.29) μmol/L ] after treatment than that before treatment (P < 0.05 ).6-K-PGF1a was obviously higher in the experimental group[(328.4±99.6) ng/L] and the control group[ (234.5±96.2) ng/L] after treat-ment than that before treatment (P<0.05).TXB2 and homoeysteine in the experimental group were obviously lower than those in the control group after treatment(P<0.05). 6-K-PGF1 a in the experimental group was obviously high-er than those in the control group after treatment (P<0.05).Conclusion Shuxuetong injection could degrade the level of TXB2 and HCY, increase the level of PGF1 a and improve the balance of TXB2/PGF1a, so Shuxuetong is ef-fective in treating acute coronary syndrome.

3.
Clinical Medicine of China ; (12): 316-317, 2008.
Article in Chinese | WPRIM | ID: wpr-401286

ABSTRACT

Objective To study the influence of Nictinamide on the endotheline(ET-1)in patienta with pulmonary arterial hypertension(PAH).Methods 66 cases of PAH were divided randomly into two groups (n=33for each):the Nictinamide treatment group and the control group.The changes of endotheline were compared before and after treatment.Results After treatment serum endotheline was significantly lower in the treatment group(P<0.01),but there was no difference in the control group before and aftertreatment(P>0.05).The significant difference was observed between treatment group and control group(P<0.01).Conclusion Nictinamide will reduce the level of endothellne and confers some degree therapeutic and preventive value for PAH.

4.
Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care ; (6)2006.
Article in Chinese | WPRIM | ID: wpr-528333

ABSTRACT

Objective: To investigate the mechanisms of curative effect of Tongxinluo capsule(通心络胶囊) on patients with coronary artery disease and angina pectoris.Methods: One hundred and twelve cases in accord with the diagnostic criteria of coronary heart disease of World Health Organization(WHO) were(randomly) divided into two groups: treatment group(n=60) and control group(n=52).The patients in both groups were treated with routine therapy including ?receptor retardant and ester of nitric acid etc.(Additionally),the treatment group was treated with Tongxinluo capsules,2 capsules each time and 2 times(per day) for 2 months consecutively.The clinical manifestations before and after treatment,the changes of(electrocardiogram)(ECG),microcirculation of nail bed and hemorrheology were observed in all the patients in both groups.Results: The total clinical effective rate and the rate of total improvement in ECG changes were 86.67% and 80.00% respectively after treatment in the treatment group,and compared with the control group(78.85% and 69.23%) the differences were significant(both P

SELECTION OF CITATIONS
SEARCH DETAIL